The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
After years of legal uncertainty, the U.S. Supreme Court removed one of the biggest risks facing Bayer, sending its shares to the largest one-day surge in 23 years. The court ruled in favor of the company in lawsuits related to its Roundup weedkiller, bolstering its legal standing and easing compensation pressures. The decision marks a turning point after years of litigation that weighed on the stock.
Bayer shares had been depressed under the weight of thousands of Roundup-related lawsuits, which cost the company billions of dollars in prior settlements. Analysts noted that the ruling removes a significant overhang, potentially leading to a re-rating by investors. This legal victory is seen as a potential catalyst for the German pharmaceutical and agriculture giant.
Sign in to access this content
Sign InBAYRY closed at $11.25 on June 24, 2026, after touching an intraday high of $11.39. Traders are now watching whether the stock can break through resistance near $11.40, and will look to Bayer's upcoming quarterly results to gauge the financial impact of the ruling.